Across disease status
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 44-4 | 122 |
| Healthy/control | 44-4 | 38 |
How the selected metric shifts among healthy, primary, metastatic, and non-cancer disease samples.
| Group | Median | Samples |
|---|---|---|
| Primary cancer | 44-4 | 122 |
| Healthy/control | 44-4 | 38 |
How the same metric changes across tissue contexts after the current filters and tier are applied.
| Group | Median | Samples |
|---|---|---|
| Lymphoid tissue | 55-5 | 1 |
| Liver | 44-4 | 3 |
| Breast | 44-4 | 156 |
The combined comparison, useful for separating disease effects from tissue composition.
| Group | Median | Samples |
|---|---|---|
| Primary cancer x Lymphoid tissue | 55-5 | 1 |
| Healthy/control x Liver | 44-4 | 3 |
| Primary cancer x Breast | 44-4 | 121 |
| Healthy/control x Breast | 43.5-4 | 35 |
| Group | Metric | Mean | Samples | Datasets |
|---|---|---|---|---|
| Primary cancer | Graph nodes | 3.975 | 122 | 2 |
| Healthy/control | Graph nodes | 3.711 | 38 | 1 |